RHYTHMIC drums and spirited dancing are once again bringing life to the shrines of Pakistan’s saints, where festivals were long stifled by jihadist violence.
As the harvest season ends and schools finish for the summer, villagers climb atop tractor trolleys, buses, and rickshaws to head to the celebrations at Sufi shrines dotted across the country.
“Those who cannot meet during the rest of the year reunite at the fair,” said Muhammad Nawaz, a farmer from Punjab province, at the annual “mela” to honour saint Shah Jiwana in Jhang city. “These fairs and Punjab’s culture share a profound connection, one of love and brotherhood,” he added.
Fairgrounds, musicians, traditional wrestlers, and motorcycle acrobats delight pilgrims lit by lanterns of all colours, but always under the watchful eye of hundreds of police officers.
Centuries-old Sufi orders across the Islamic world have millions of followers, from Turkey to South Asia, and their beliefs are rooted in mysticism and a devotion to saints. Many orthodox hardliners consider Sufi beliefs heretical, however, and Sunni militant groups such as the Pakistani Taliban and Daesh (Islamic State) have carried out bloody attacks at shrines and festivals.
In Pakistan, the attacks led authorities to ban festivals or limit their activities until recently. “The goal was to avoid risking public lives,” said Alloudin Mehmood, a government official at Bari Imam shrine in Islamabad, targeted by a 2005 suicide bombing that killed 19 people.
Security has improved after several military operations, aallowing celebrations to gradually return. “Only after receiving security clearance was the festival permitted last year, ending a 16-year hiatus,” Mehmood added.
The event was shortened from five days to three, with mobile phone signals suspended for security reasons.
The landscape of rural Pakistan is adorned with thousands of Sufi shrines, varying in size from grand edifices to modest structures, each steeped in a tapestry of associated legends.
“There are cities which emerged around these shrines and melas,” said author and anthropologist Haroon Khalid. Particularly in Punjab and Sindh, saints, referred to as “Pirs,” are revered and miracles are attributed to their spiritual presence.
“These shrines have endured threats and persecution,” said anthropologist and author Zulfiqar Ali Kalhoro. “Culture always has a remarkable resilience, capable of absorbing shocks and persevering through challenging times.
” The annual celebrations commemorate the anniversaries of a saint’s death and symbolise the spiritual union between devotees and the divine.
“Pilgrims find solace, healing, release, and entertainment at these events that celebrate the ‘friends of God’,” said Carl W Ernst, who has authored several books on Sufism. Sufism has inspired some of Pakistan’s beloved artists, writers, and musicians.
Sufi shrines often attract marginalised groups, including transgender women and drug addicts. “We are never as well-received as at festivals,” said Khusbhoo, a transgender woman.
At the Shah Jiwana shrine, devotion gives way to entertainment in the late afternoon. A juice seller belts out a famous Punjabi song: “Forget about your responsibilities for a while; let’s head to the fair instead.” Thousands turn to the fields to witness traditional games such as kabaddi, and tent pegging, a more graceful display of horsemanship.
Against the neon background of the fairgrounds, 16-year-old stunt girl Fatima Noor prepares her motorbike. Defying both gravity and social taboos, she circles the “wall of death” to the amazement of the crowd – a chance to earn some money for her family.
“These fairs must be held, as we do not have any other employment opportunities,” she said.
Eighteen-year-old Hamid Ijaz, delighted in the celebrations, said, “Because of how widespread hate and sectarianism are in our country, it’s crucially important to organise events like these where everyone can come together and foster love.” (APF )
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.